Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
about
Translating Treg Therapy in Humanized MiceAdvancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient miceDendritic cell-based vaccination in cancer: therapeutic implications emerging from murine modelsDysregulation of claudin-5 in HIV-induced interstitial pneumonitis and lung vascular injury. Protective role of peroxisome proliferator-activated receptor-γ.Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDSZinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment.Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice.Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice.Humanized mice as a model for aberrant responses in human T cell immunotherapy.Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles.Human PBMC-transferred murine MHC class I/II-deficient NOG mice enable long-term evaluation of human immune responses.Creation of a long-acting nanoformulated dolutegravir.Functional engraftment of human peripheral T and B cells and sustained production of autoantibodies in NOD/LtSzscid/IL-2Rγ(-/-) mice.
P2860
Q26772335-EC0DF1E5-D015-46AF-8EA0-44DBF7DF81B2Q27008307-BA5FD24D-DC92-462A-8C45-629543ACF4CCQ27012618-BDF875CE-CA3C-4775-B561-9B20182CC0A9Q34480264-B5D55D72-270B-4713-B0A5-5E1266CA50F5Q35028750-F7C8840F-C3A3-428E-B292-8B36EB1D393AQ35876209-7BFB6047-2A92-4819-B608-5F397124B8B7Q36603756-4A6EC9D6-9A95-4212-BD65-3924D3901D65Q39571861-721D7AAB-E1F5-4FB9-8314-A37AB240E95EQ41816196-07C7CF10-BDBE-495A-9F72-27FAC55236C8Q47603651-8AF88DF6-1DA7-4AA1-BC89-C6E0763573FDQ49900917-7589BFFD-45E0-4E17-BB6E-8A8C593B5D3AQ50051618-1BABF237-2921-49BB-8258-D30A0C0316A0Q50784754-0DFD717A-2AED-456D-A3BD-CD785C3821C1
P2860
Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development of novel major his ...... eic graft-versus-host disease.
@ast
Development of novel major his ...... eic graft-versus-host disease.
@en
type
label
Development of novel major his ...... eic graft-versus-host disease.
@ast
Development of novel major his ...... eic graft-versus-host disease.
@en
prefLabel
Development of novel major his ...... eic graft-versus-host disease.
@ast
Development of novel major his ...... eic graft-versus-host disease.
@en
P2093
P2860
P1476
Development of novel major his ...... eic graft-versus-host disease.
@en
P2093
Bruce Gott
Dale L Greiner
Jennifer Wagner
Laurence Covassin-Barberis
Leonard D Shultz
Lisa Burzenski
Marie King
Michael A Brehm
Oded Foreman
Steve Pino
P2860
P304
P356
10.1007/978-1-60761-058-8_7
P407
P577
2010-01-01T00:00:00Z